行情

VIVE

VIVE

Viveve Medical
NASDAQ

实时行情|Nasdaq Last Sale

3.330
+0.310
+10.26%
已收盘, 19:08 11/19 EST
开盘
3.010
昨收
3.020
最高
3.395
最低
3.000
成交量
25.39万
成交额
--
52周最高
244.22
52周最低
2.961
市值
492.02万
市盈率(TTM)
-0.0354
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

VIVE 新闻

  • 云集12月2日发布2019年第三季度财报
  • 新浪科技.38分钟前
  • 拼多多Q3净亏损超预期 盘前跌逾20%市值回落百度之后
  • 新浪财经.2小时前
  • 拼多多三季度营收低于市场预期 盘前大跌13%
  • 新浪科技.2小时前
  • 定价176港元,阿里巴巴首日盈利空间还有多大?
  • 华盛通.2小时前

更多

所属板块

先进医疗设备和技术
+1.39%
医疗设备和用品
+1.01%

热门股票

名称
价格
涨跌幅

VIVE 简况

Viveve Medical, Inc. designs, develops, manufactures and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The Company's, Geneveve, is a non-invasive solution for vaginal laxity, which includes three components: the Viveve System (a radio frequency (RF), generator housed in a table-top console), a reusable handpiece and a single-use treatment tip, as well as several other consumable accessories. Physicians attach the single-use treatment tip to the handpiece, which is connected to the console. The generator authenticates the treatment tip and programs the system for the desired treatment without further physician intervention. The treatment is performed in a physician's office, in less than 30 minutes, and does not require the use of anesthesia. Geneveve is indicated for use in general surgical procedures for electrocoagulation and hemostasis in the United States.
展开

Webull提供Viveve Medical Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。